Dataset Information


Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion.

ABSTRACT: Notch3 gene amplification and pathway activation have been reported in ovarian serous carcinoma. However, the primary Notch3 ligand that initiates signal transduction in ovarian cancer remains unclear. In this report, we identify Jagged-1 as the highest expressed Notch ligand in ovarian tumor cells as well as in peritoneal mesothelial cells that are in direct contact with disseminated ovarian cancer cells. Cell-cell adhesion and cellular proliferation were reduced in Notch3-expressing ovarian cancer cells that were cocultured with Jagged-1 knockdown mesothelial and tumor feeder cells. Interaction of Notch3-expressing ovarian cancer cells with Jagged-1-expressing feeder cells activated the promoter activity of candidate Notch3 target genes, and this activity was attenuated by Notch3 siRNA. Constitutive expression of the Notch3 intracellular domain significantly suppressed the Jagged-1 shRNA-mediated growth inhibitory effect. In Notch3-expressing ovarian cancer cells, Jagged-1-stimulating peptides enhanced cellular proliferation, which was suppressed by gamma-secretase inhibitor and Notch3 siRNA. Taken together, our results show that Jagged-1 is the primary Notch3 ligand in ovarian carcinoma and Jagged-1/Notch3 interaction constitutes a juxtacrine loop promoting proliferation and dissemination of ovarian cancer cells within the intraperitoneal cavity.


PROVIDER: S-EPMC2562671 | BioStudies | 2008-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5520050 | BioStudies
2014-01-01 | S-EPMC4058356 | BioStudies
2010-01-01 | S-EPMC2953807 | BioStudies
2014-01-01 | S-EPMC5568695 | BioStudies
2014-01-01 | S-EPMC4135574 | BioStudies
2015-01-01 | S-EPMC4649895 | BioStudies
2008-01-01 | S-EPMC2636690 | BioStudies
2012-01-01 | S-EPMC3342447 | BioStudies
2017-01-01 | S-EPMC5648607 | BioStudies
2007-01-01 | S-EPMC1803033 | BioStudies